Magnetic Particle Imaging : From Tracer Design to Biomedical Applications in Vasculature Abnormality

© 2023 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 17 vom: 01. Apr., Seite e2306450
1. Verfasser: Xie, Xulin (VerfasserIn)
Weitere Verfasser: Zhai, Jiao, Zhou, Xiaoyu, Guo, Zhengjun, Lo, Pui-Chi, Zhu, Guangyu, Chan, Kannie W Y, Yang, Mengsu
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Review image‐guided therapy magnetic nanoparticle tracers magnetic particle imaging medical diagnosis vasculature abnormality Magnetite Nanoparticles Contrast Media
Beschreibung
Zusammenfassung:© 2023 Wiley‐VCH GmbH.
Magnetic particle imaging (MPI) is an emerging non-invasive tomographic technique based on the response of magnetic nanoparticles (MNPs) to oscillating drive fields at the center of a static magnetic gradient. In contrast to magnetic resonance imaging (MRI), which is driven by uniform magnetic fields and projects the anatomic information of the subjects, MPI directly tracks and quantifies MNPs in vivo without background signals. Moreover, it does not require radioactive tracers and has no limitations on imaging depth. This article first introduces the basic principles of MPI and important features of MNPs for imaging sensitivity, spatial resolution, and targeted biodistribution. The latest research aiming to optimize the performance of MPI tracers is reviewed based on their material composition, physical properties, and surface modifications. While the unique advantages of MPI have led to a series of promising biomedical applications, recent development of MPI in investigating vascular abnormalities in cardiovascular and cerebrovascular systems, and cancer are also discussed. Finally, recent progress and challenges in the clinical translation of MPI are discussed to provide possible directions for future research and development
Beschreibung:Date Completed 25.04.2024
Date Revised 03.05.2024
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202306450